Calvin Pan, MD
Enriched profileClinical Professor, Department of Medicine (also styled Professor of Medicine), NYU Grossman School of Medicine · NYU Langone Health
Calvin Pan is Clinical Professor, Department of Medicine (also styled Professor of Medicine), NYU Grossman School of Medicine at NYU Langone Health. OpenAlex indexes 214 publications with 7,877 citations (h-index 40); ClinicalTrials.gov lists 8 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Calvin Q. Pan, MD, is Clinical Professor, Department of Medicine (also styled Professor of Medicine), NYU Grossman School of Medicine at NYU Langone Health / NYU Grossman School of Medicine, Division of Gastroenterology and Hepatology, Tisch Hospital. The public record shows 214 publications with 7,877 citations (h-index 40), centered on Hepatitis B Virus Studies, Hepatitis C virus research, Liver Disease Diagnosis and Treatment. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 28 companies.
- Most recent indexed publication: 2026 · Hepatology (Baltimore, Md.)
- Top research focus: Hepatitis B Virus Studies
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 28 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 48 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 87.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Public positions
sourced statements on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
- Chair
AASLD Hepatitis B Special Interest Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - Chair
AASLD Online Learning Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Chronic HBV Infection in Pregnant Women Taking TAF to Prevent Vertical Transmission
Sponsor: New Discovery LLC
- Maternal Therapy With TAF Versus TDF to Prevent Vertical Transmission of Hepatitis B
Sponsor: New Discovery LLC
Industry payments
Updated 14 Oct 2026
28 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20253 payments
- Gilead Sciences, Inc.Program year20257 payments
- ABBVIE INC.Program year20253 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
87.6%Proton pump inhibitor22.1%Esomeprazole Magnesium64%Dexlansoprazole Dr18%Omeprazole11%Pantoprazole Sodium6%Part D<11 patientsAluminum Complex21.9%Sucralfate100%Part D≥106 patients+ 11 more classes in this area
Anti-infectives
10.4%Nucleoside and nucleotide reverse transcriptase inhibitors9.4%Vemlidy100%Part D≥24 patientsHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor1%Entecavir100%Part D<11 patientsSensory organs
2.1%Corticosteroid2.1%Proctozone-Hc100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 14 Oct 2026
1 congress contribution (2025) across ASCO per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Technical systematic review supporting the 2025 AASLD Practice Guideline on management of chronic hepatitis B.
Hepatology (Baltimore, Md.)
Review2026 - Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment.
Alimentary pharmacology & therapeutics
Clinical Trial2026 - Tenofovir Alafenamide Therapy Throughout Pregnancy in Mothers With Hepatitis B.
Alimentary pharmacology & therapeutics
Article2025 - Novel Approach: Maternal Tenofovir Alafenamide Prophylaxis to Prevent Hepatitis B Virus Transmission.
Clinical infectious diseases
Article2025
Most-cited works
by citation count (OpenAlex)Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
aasld.org/tlm-25/calvin-q-pan
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - Other
globalhep.org/dr-calvin-pan
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →globalhep.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nyulangone.org ↗
- Residency
Internal Medicine, Long Island Jewish Medical Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aasld.org ↗ - Fellowship
Gastroenterology and Hepatology, Stony Brook University Hospital
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aasld.org ↗
Editorial & leadership roles
journal and society appointments- Associate Editor
World Journal of Hepatology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmc.ncbi.nlm.nih.gov ↗ - Associate Editor
Liver Research (KeAi Publishing)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →keaipublishing.com ↗
Awards & honors
honors on the public record- James D. Bruce Memorial Award for Distinguished Contributions in Preventive Medicine
American College of Physicians
2018verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org ↗
- Outstanding Contribution Award
Chinese Society of Infectious Diseases
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nyulangone.org ↗
Secondary affiliations
appointments beyond the home institution- Center of Liver Diseases
Capital Medical University Affiliated Beijing Ditan Hospital, Beijing, China
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onlinelibrary.wiley.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Gareth Morgan, MD
NYU Langone Health
Nathan Levin, MD
NYU Langone Health
Ira Jacobson, MD
NYU Langone Health
Michael Zelefsky, MD
NYU Langone Health
Paul Ridker, MD
Brigham and Women's Hospital
Edward Giovannucci, MD, ScD, MPH
Harvard T.H. Chan School of Public Health
Stephen Chanock, MD
National Cancer Institute (NCI)
Wei Zheng, MD, PhD, MPH
Vanderbilt University Medical Center